Jeff brings extensive industry expertise to A2-Ai, with over 20 years of experience in DMPK in biotech and big pharma. Jeffrey is an expert in PK study design, analysis, and modeling, and has a proven track record of collaborating across teams to foster data-driven decision-making and accelerate drug candidates from discovery through clinical development.